Akzo Nobel Gets Organon Bids

Akzo Nobel NV has received three bids for its pharmaceutical unit Organon BioSciences, according to Dow Jones. Each is in the range of Euro 8 billion to Euro 10 billion. One consortium includes Blackstone Group, Bain Capital, Alpinvest Partners NV, Apax Partners and Texas Pacific Group. The second includes KKR and Warburg Pincus, while members of the third are Carlyle Group, Advent International and BC Partners.